Balyasny Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $83.9 Million - $98.2 Million	848,150 Added 62.15%	2,212,745 $256 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $48.4 Million - $56.4 Million	502,189 Added 58.23%	1,364,595 $140 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $79.6 Million - $84.2 Million	-741,412 Reduced 46.23%	862,406 $94.1 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $27.5 Million - $50.1 Million	440,287 Added 37.84%	1,603,818 $183 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $68.6 Million - $98.5 Million	1,163,531 New	1,163,531 $72 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $33.7 Million - $40.4 Million	-366,372 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $25.9 Million - $28.8 Million	299,979 Added 451.82%	366,372 $34.3 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $4.77 Million - $6.34 Million	66,393 New	66,393 $6.11 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $12 Million - $15.1 Million	-178,635 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $6.8 Million - $9.83 Million	123,042 Added 221.33%	178,635 $13.9 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $12.4 Million - $23.5 Million	-411,656 Reduced 88.1%	55,593 $3.09 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $12.1 Million - $18.8 Million	-488,028 Reduced 51.09%	467,249 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $17.2 Million - $24.8 Million	675,840 Added 241.86%	955,277 $34.6 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $13.1 Million - $16 Million	-570,560 Reduced 67.12%	279,437 $7.61 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $19.4 Million - $24.2 Million	849,997 New	849,997 $20.5 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account